Identification of Endogenous Glucocorticoid Repressed Genes Differentially Regulated by a Glucocorticoid Receptor Mutant Able to Separate between Nuclear Factor-κB and Activator Protein-1 Repression
Abstract
Glucocorticoids are commonly used in the clinic, but long-term treatment is often associated with severe side effects. One way to reduce unwanted effects is to restrict glucocorticoid receptor (GR) signaling through defined pathways. In this study, we examine endogenous target genes regulated by a GR mutant that in contrast to the wild-type GR is unable to repress stimulated nuclear factor-kappaB (NF-kappaB) activity, whereas repression of activator protein-1 (AP-1) activity is maintained. This GR mutant (GRR488Q) harbors a point mutation in the second zinc finger of the DNA binding domain. Its ability to distinguish between NF-kappaB and AP-1 repression is defined using reporter genes regulated by both simple and natural promoters. The inability of GRR488Q to repress NF-kappaB was not related to its inability to activate target genes through a glucocorticoid response element. Furthermore, the discriminating property was observed in three different cell lines, suggesting that this is not a cell-specific effect. These results show that different receptor surfaces or mechanisms are involved in repression of NF-kappaB and AP-1, respectively. It is interesting that the GRR488Q still interacted physically with NF-kappaB. Gene expression profiling of human embryonic kidney 293 cells, which express the wild-type GR and the GRR488Q mutant allowed identification of endogenous genes preferentially repressed by GR interference with NF-kappaB activity. The genes differentially regulated by GRR488Q mutant versus the wild-type GR after 2 h of treatment seem mainly to be involved in control of transcription and cell growth. At 8 h, no such distinction could be seen.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Different GR domains are responsible for NF-κB and AP-1 interactions.
“This role may not be the same as that for NF-κB because different GR domains are responsible for NF-κB and AP-1 interactions (Bladh et al., 2005).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as Bladh et al., 2005
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · see citing works
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 2× · see citing works
“…factors have been shown to be crucial for the induction of a number of genes involved in many biological processes (e.g., inflammation, differentiation, cell proliferation, apoptosis, and oncogenesis) (Karin and Chang, 2001; Shaulian and Karin, 2001; Ghosh and Karin, 2002; Karin et al., 2002).”
BackgroundNF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476 · see citing works
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390 · see citing works
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150 · see citing works
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847 · see citing works
AP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,733 · see citing works
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676 · see citing works
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553 · see citing works
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,544 · see citing works
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P. N., Kliewer, S. A., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,204 · see citing works
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · see citing works
Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J.-Α., & Nilsson, S. V. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.105 · Cited by 770 · see citing works
Functional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675 · see citing works
Schmedtje, J. F., Ji, Y.-S., Liu, W. L., DuBois, R. N., & Runge, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.601 · Cited by 668 · see citing works
Berger, J., Hauber, J., Hauber, R., Geiger, R. E., & Cullen, B. R. (1988) · Gene · doi:10.1016/0378-1119(88)90219-3 · Cited by 667 · see citing works
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559 · see citing works
The AP-1 site and MMP gene regulation: What is all the fuss about?
Benbow, U., & Brinckerhoff, C. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90026-3 · Cited by 521 · see citing works
Heck, S., Kullmann, M. K., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P. A., & Cato, A. C. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 516 · see citing works
Caldenhoven, E., Lidén, J., Wissink, S., van de Stolpe, A., Raaijmakers, J. A. M., Koenderman, L., Okret, S., Gustafsson, J., & van der Saag, P. T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659084 · Cited by 490 · see citing works
Inoue, H., Yokoyama, C., Hara, S., Tone, Y., & Tanabe, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24965 · Cited by 479 · see citing works
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M., Tuckermann, J. P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., & Schütz, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429 · see citing works
Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β
Newton, R. C., Kuitert, L. M. E., Bergmann, M., Adcock, I. M., & Barnes, P. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7064 · Cited by 390 · see citing works
Bosscher, K. D., Berghe, W. V., Vermeulen, L., Plaisance, S., Boone, E., & Haegeman, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3919 · Cited by 335 · see citing works
Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305 · see citing works
van de Stolpe, A., Caldenhoven, E., Stade, B. G., Koenderman, L., Raaijmakers, J. A. M., Johnson, J. P., & van der Saag, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37586-5 · Cited by 264 · see citing works
Caldenhoven, E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.401 · Cited by 260 · see citing works
Belvisi, M. G., Wicks, S., Battram, C. H., Bottoms, S. E., Redford, J., Woodman, P., Brown, T. J., Webber, S. E., & Foster, M. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1975 · Cited by 186 · see citing works
Monoclonal antibodies against the rat liver glucocorticoid receptor.
Okret, S., Wikström, A. C., Wränge, Ö., Andersson, B., & Gustafsson, J.-Α. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1609 · Cited by 183 · see citing works
Rogatsky, I., Zarember, K. A., & Yamamoto, K. R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6071 · Cited by 170 · see citing works
AP-1--glucocorticoid receptor crosstalk taken to a higher level
Karin, M., & Chang, L. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690447 · Cited by 167 · see citing works
A New Function for the C-terminal Zinc Finger of the Glucocorticoid Receptor
Lidén, J., Delaunay, F., Rafter, I., Gustafsson, J.-Å., & Okret, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21467 · Cited by 155 · see citing works
Brüggemeier, U., Rogge, L., Winnacker, E. ‐., & Beato, M. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07393.x · Cited by 132 · see citing works
McEvoy, A. N., Murphy, E., Pönniö, T., Conneely, O. M., Bresnihan, B., FitzGerald, O., & Murphy, E. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2979 · Cited by 113 · see citing works
Tao, Y., Williams-Skipp, C., & Scheinman, R. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000526200 · Cited by 96 · see citing works
Glucocorticoid Repression of AP-1 Is Not Mediated by Competition for Nuclear Coactivators
Bosscher, K. D., Berghe, W. V., & Haegeman, G. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.2.0591 · Cited by 95 · see citing works
Human Activin βA Gene IDENTIFICATION OF NOVEL 5′
Tanimoto, K., Yoshida, E., Mita, S., Nibu, Y., Murakami, K., & Fukamizu, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32760 · Cited by 52 · see citing works
Subramaniam, N., Campión, J., Rafter, I., & Okret, S. (2003) · Biochemical Journal · doi:10.1042/bj20020471 · Cited by 28 · see citing works
Wu, J., Yu, L., Dietz, J. D., & Lala, D. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0373 · Cited by 27 · see citing works
Frazier-Jessen, M. R., Thompson, C. D., Brown, R., Rawat, R., Nordan, R. P., & Feldman, G. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02295-0 · Cited by 23 · see citing works
Balliet, A. G., Hatton, K. S., Hoffman‐Liebermann, B., & Liebermann, D. A. (2001) · DNA and Cell Biology · doi:10.1089/104454901750219125 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · see citing works
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647 · see citing works
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425 · see citing works
Newton, R. C., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 325 · see citing works
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298 · see citing works
Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
De Bosscher, K., & Haegeman, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0283 · Cited by 284 · see citing works
Anti-inflammatory functions of glucocorticoid-induced genes
Clark, A. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.013 · Cited by 272 · see citing works
Glucocorticoid Receptor-Dependent Gene Regulatory Networks
Le, P. P., Friedman, J. R., Schug, J., Brestelli, J. E., Parker, J. B., Bochkis, I. M., & Kaestner, K. H. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010016 · Cited by 250 · see citing works
Corticosteroid-related central nervous system side effects
Ciriaco, M., Ventrice, P., Russo, G., Scicchitano, M., Mazzitello, G., Scicchitano, F., & Russo, E. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.120975 · Cited by 247 · see citing works
Schäcke, H., Berger, M., Rehwinkel, H., & Asadullah, K. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.014 · Cited by 223 · see citing works
Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor
Escoter-Torres, L., Caratti, G., Mechtidou, A., Tuckermann, J. P., Uhlenhaut, N. H., & Vettorazzi, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01859 · Cited by 146 · see citing works
Karmakar, S., Jin, Y., & Nagaich, A. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.473819 · Cited by 137 · see citing works
Cryptic glucocorticoid receptor-binding sites pervade genomic NF-κB response elements
Hudson, W. H., de Vera, I. M. S., Nwachukwu, J. C., Weikum, E. R., Herbst, A., Yang, Q., Bain, D. L., Nettles, K. W., Kojetin, D. J., & Ortlund, E. A. (2018) · Nature Communications · doi:10.1038/s41467-018-03780-1 · Cited by 131 · see citing works
Newton, R. C., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 114 · see citing works
Sharma, S., & Lichtenstein, A. K. (2008) · Blood · doi:10.1182/blood-2007-11-124156 · Cited by 78 · see citing works
Bosscher, K. D., Beck, I. M. E., Dejager, L., Bougarne, N., Gaigneaux, A., Chateauvieux, S., Ratman, D., Bracke, M., Tavernier, J. H., Berghe, W. V., et al. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1367-4 · Cited by 75 · see citing works
Nuclear receptors in inflammation control: Repression by GR and beyond
Chinenov, Y. V., Gupte, R., & Rogatsky, I. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.006 · Cited by 61 · see citing works
Mechanisms of Glucocorticoid-Regulated Gene Transcription
Meijsing, S. H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_3 · Cited by 53 · see citing works
Mao, X., Stewart, A. K., Hurren, R., Datti, A., Zhu, X., Zhu, Y., Shi, C., Lee, K., Tiedemann, R. E., Eberhard, Y., et al. (2007) · Blood · doi:10.1182/blood-2007-05-088666 · Cited by 55 · see citing works
Johansson-Haque, K., Palanichamy, E., & Okret, S. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0015 · Cited by 53 · see citing works
Glucocorticoid receptor mutants: man-made tools for functional research
Beck, I. M. E., Bosscher, K. D., & Haegeman, G. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.03.009 · Cited by 44 · see citing works
A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs
Li, M., & Yang, X. (2011) · PPAR Research · doi:10.1155/2011/742785 · Cited by 42 · see citing works
Medin, C. L., & Rothman, A. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/502630 · Cited by 34 · see citing works
Bladh, L.-G., Johansson-Haque, K., Rafter, I., Nilsson, S. V., & Okret, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.013 · Cited by 32 · see citing works
From willow bark to peptides: the ever widening spectrum of NF-κB inhibitors
D’Acquisto, F., & Ianaro, A. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.009 · Cited by 31 · see citing works
Rosenberg, A. S. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2136950 · Cited by 31 · see citing works
Carbon-Ion-Induced Activation of the NF-κB Pathway
Hellweg, C. E., Baumstark‐Khan, C., Schmitz, C., Lau, P., Meier, M. M., Testard, I., Berger, T., & Reitz, G. (2011) · Radiation Research · doi:10.1667/rr2423.1 · Cited by 29 · see citing works
Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling
Dougherty, E. J., Elinoff, J. M., Ferreyra, G. A., Hou, A., Cai, R., Sun, J., Blaine, K., Wang, S., & Danner, R. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732248 · Cited by 19 · see citing works
Bonamassa, B., & Liu, D. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.005 · Cited by 16 · see citing works
Revisiting steroid treatment for septic shock: molecular actions and clinical effects - a review
Japiassú, A. M., Salluh, J. I., Bozza, P. T., Bozza, F. A., & Castro-Faria-Neto, H. C. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000400001 · Cited by 15 · see citing works
Singh, M., Agarwal, V., Jindal, D., Pancham, P., Agarwal, S., Mani, S., Tiwari, R. K., Das, K., Alghamdi, B. S. A., Abujamel, T. S., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13030337 · Cited by 15 · see citing works
Associated inflammatory response in pneumonia: role of adjunctive therapy with glucocorticoids
Rañó, A., Agustı́, C., Sibila, O., & Torres, A. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000216629.51563.f8 · Cited by 13 · see citing works
Transrepression and transactivation potencies of inhaled glucocorticoids
Dirks, N. L., Li, S., Huth, B. J., Hochhaus, G., Yates, C. R., & Meibohm, B. (2008) · Die Pharmazie · doi:10.31083/ph.2008.8638 · Cited by 12 · see citing works
Lu, J. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.02.009 · Cited by 10 · see citing works
Hellweg, C. E., Dilruba, S., Adrian, A., Feles, S., Schmitz, C., Berger, T., Przybyla, B., Briganti, L., Franz, M., Segerer, J., et al. (2015) · Life Sciences in Space Research · doi:10.1016/j.lssr.2015.10.003 · Cited by 9 · see citing works
Gu, L., Han, Y., Liu, W., Mao, Y., Li, J., & Wang, H. (2013) · Inflammation Research · doi:10.1007/s00011-013-0680-6 · Cited by 8 · see citing works
Lim, W., Jung, J.-S., Surh, Y., Inoue, H., & Lee, Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.03.014 · Cited by 8 · see citing works
Lim, W., Park, M.-K., Bahn, J., Inoue, H., & Lee, Y. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.077 · Cited by 8 · see citing works
Wang, X., Li, Y., Zhu, X., Wang, Y., Diao, F., & Lu, J. G. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0021 · Cited by 8 · see citing works
Improving data interpretability with new differential sample variance gene set tests
Rahmatallah, Y., & Glazko, G. V. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06117-0 · Cited by 1 · see citing works
Effect of p16 on glucocorticoid response in a B-cell lymphoblast cell line
Kim, S., Lee, K., Jeong, D. C., & Kim, H.-K. (2010) · Korean Journal of Pediatrics · doi:10.3345/kjp.2010.53.7.753 · Cited by 1 · see citing works
Anti‐Inflammatory Glucocorticoids
Avery, M. A., & Chittiboyina, A. G. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc192 · Cited by 1 · see citing works
Novel Glucocorticoid Receptor Ligands
Schäcke, H., Asadullah, K., Berger, M., & Rehwinkel, H. (2008) · Methods and principles in medicinal chemistry · doi:10.1002/9783527623297.ch9 · Cited by 1 · see citing works
Molecular Mechanisms of Glucocorticoid Receptor Action
Bhavsar, P. K., & Adcock, I. M. (2008) · doi:10.1002/9780470985731.ch1
The Role of Luteal Phase Fallopian Tube Epithelium in High-grade Ovarian Serous Carcinoma
Tone, A. A. (2010) · TSpace (University of Toronto)
Al-Ibadi, I. N. A. (2017) · University of Salford Institutional Repository (University of Salford)
Anti‐Inflammatory Glucocorticoids
Avery, M. A., & Chittiboyina, A. G. (2021) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc192.pub2
Pyridin-2(1H)one derivatives - a new class of therapeutics for trigeminal pain
Murail, P. (2024) · theses.fr (ABES) · doi:10.70675/ad8d129azce02z4a4dz9aa8zea61b5651e61
- Authors
- Bladh, L.-G., Lidén, J., Dahlman-Wright, K., Reimers, M., Nilsson, S., & Okret, S.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- National Institutes of Health (US)
- Karo Pharma (Sweden) (SE)
- ORCID
- Okret, Sam
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 67
- Issue
- 3
- Pages
- 815-826
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2036130822
- Cited by
- 49
- References
- 41
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 5
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- glucocorticoid receptor, zinc finger mutations, glucocorticoid response element, transcriptional repression, gene expression profiling, transcriptional regulation, cell growth regulation
- MeSH terms
- Animals, Base Sequence, Cell Line, Chlorocebus aethiops, Dexamethasone, Gene Expression Regulation, Glucocorticoids, Humans, Kinetics, Phosphatidylethanolamines, Receptors, Glucocorticoid, NF-kappa B, Zinc Fingers, Point Mutation, Genes, Reporter, DNA Primers, Transcription Factor AP-1, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review